Among the four MLH1-mutant tumors, complete loss of both MLH1 and PMS2 IHC in the tumor cells was present in three cases (Patient #1, 9, and 10), but one case showed complete loss of MLH1 and heterogeneous loss of the partner protein PMS2 (Patient #11). Here, PMS2 is linked to neoplasm.